Understanding how a specific protein affects beta cells in type 1 diabetes
The role of beta cell ATF6 in type 1 diabetes
This study is looking at how a protein called ATF6 affects the health of insulin-producing cells in the pancreas, which is important for people with type 1 diabetes, to find ways to help these cells survive stress and improve diabetes treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10874761 on NIH RePORTER |
What this research studies
This research investigates the role of the ATF6 protein in the health of pancreatic beta cells, which are crucial for insulin production. It focuses on how stress responses within these cells can lead to their death, contributing to type 1 diabetes. By using a preclinical model with genetically modified mice, the study aims to uncover the mechanisms that determine whether beta cells adapt to stress or undergo apoptosis. This could lead to new therapeutic strategies to protect beta cells and improve diabetes management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 1 diabetes who may benefit from new therapeutic approaches targeting beta cell preservation.
Not a fit: Patients with type 2 diabetes or other forms of diabetes unrelated to beta cell dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel treatments that preserve beta cell function in patients with type 1 diabetes.
How similar studies have performed: Other research has shown promise in targeting stress responses in beta cells, suggesting that this approach could lead to significant advancements in diabetes treatment.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Engin, Feyza — University of Wisconsin-Madison
- Study coordinator: Engin, Feyza
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.